Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumorsSijin Li, Ming Shi, Yi-Fei Xia et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2024Cited by 15
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)Rui Hou, Junying Xu, Xi Wu et al.|International Journal of Oncology|2025Cited by 14
Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon CancerJunli Ding, Junying Xu, Yuting Li et al.|International Journal of General Medicine|2023Cited by 7
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-CancerWei Huang, Junli Ding, Zhengtao Qian et al.|Pharmacogenomics and Personalized Medicine|2023Cited by 6
The interaction network between intestinal flora and cell death in microecosystem of pan-cancersYuhan Zhang, Junying Xu, Cenzhu Wang et al.|International Journal of Medical Sciences|2025Cited by 1